| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/16/2011 | CA2464770C Compound |
| 08/16/2011 | CA2449002C Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin |
| 08/16/2011 | CA2412730C Method for preparing a physiologically active il-18 polypeptide |
| 08/16/2011 | CA2401624C Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/16/2011 | CA2400639C Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2376164C Intermolecularly associating compounds, and aggregates comprising them |
| 08/16/2011 | CA2369270C Camptothecin analogs and methods of preparation thereof |
| 08/16/2011 | CA2174928C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 08/11/2011 | WO2011096535A1 Pharmaceutical agent for treatment and/or prevention of cancer |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096462A1 Heterocyclic compound having npy y5 receptor antagonistic activity |
| 08/11/2011 | WO2011096414A1 Mitochondrial function improver |
| 08/11/2011 | WO2011096413A1 Agent for improving motility function |
| 08/11/2011 | WO2011096380A1 Salacia extract with reduced polyphenol content |
| 08/11/2011 | WO2010143170A3 Compounds useful for treating premature aging and in particular progeria |
| 08/11/2011 | US20110197294 Compositions and methods for restoring mitochondrial electron transfer function |
| 08/11/2011 | US20110196128 Murine zcytor17 ligand polynucleotides |
| 08/11/2011 | US20110196031 Compositions and methods for treating varicose veins |
| 08/11/2011 | US20110196028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 08/11/2011 | US20110196020 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3) |
| 08/11/2011 | US20110195980 Bicyclic Kinase Inhibitors |
| 08/11/2011 | US20110195918 Method for producing pectin hydrolysis products |
| 08/11/2011 | US20110195916 Cytokine protein family |
| 08/11/2011 | US20110195128 Treating or preventing gout |
| 08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
| 08/11/2011 | US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor |
| 08/11/2011 | US20110195024 Isatin derivatives for use as in vivo imaging agents |
| 08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | CA2788720A1 Medicament for treating and/or preventing cancer |
| 08/10/2011 | EP2354125A1 Anhydrous and hydrate polymorphic forms of antihistaminic piperidine derivatives |
| 08/10/2011 | EP2353592A1 Therapeutic causing contraction of mucosal tissue and method of treating diseases relating to mucosal tissues |
| 08/10/2011 | EP2352568A1 Administration of an adsorbent polymer for treatment of systemic inflammation |
| 08/10/2011 | EP1830853B1 Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases |
| 08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 08/10/2011 | EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 08/10/2011 | EP1496873B2 Chewable soft capsule |
| 08/10/2011 | EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/10/2011 | EP1411967B1 Blocking peptide for inflammatory cell secretion |
| 08/10/2011 | EP1383465B1 Acute pharmacologic augmentation of psychotherapy with d-cycloserine |
| 08/10/2011 | EP1358206B1 Peptide-based compounds |
| 08/10/2011 | EP1296986B1 5-aminoalkyl-pyrazolo[ 4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 08/10/2011 | DE202011004859U1 Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Beschleunigung der Regeneration nach Erkrankungen und/oder nach Leistungsspitzen Medicinal or dietary supplement for the treatment and / or accelerating the recovery from disease and / or after power peaks |
| 08/10/2011 | CN1796546B Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin |
| 08/10/2011 | CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 08/10/2011 | CN102149709A Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1H-pyrazole methanesulfonate and methods for their preparation |
| 08/10/2011 | CN102149383A Pharmaceutical agent, food or beverage having inhibitory activity on serotonin transporter |
| 08/10/2011 | CN102149375A Human Beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 08/10/2011 | CN102146411A Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament |
| 08/10/2011 | CN102145163A Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 08/10/2011 | CN102145097A Traditional Chinese medicinal composition for moistening dryness |
| 08/10/2011 | CN102145082A Chinese medical composition capable of promoting blood circulation and clearing away heat |
| 08/10/2011 | CN102145067A Traditional Chinese medicine capsule for treating bone marrow suppression caused by highly active antiretroviral therapy (HAART) for AIDS (acquired immure deficiency syndrome) |
| 08/10/2011 | CN102145037A Method for drying honeysuckle extract |
| 08/10/2011 | CN101590070B Use of baicalin in preparation of targeted organ protection medicaments |
| 08/10/2011 | CN101415702B Hetero compound |
| 08/10/2011 | CN101407782B Oral DNA vaccine for promoting growth of animal by non-antibiotics resistance gene screening, and preparation and use thereof |
| 08/10/2011 | CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 08/10/2011 | CN101330920B Liquid medicine for internal use |
| 08/10/2011 | CN101185644B Use of agomelatine in obtaining medicaments intended for the treatment of periventricular leukomalacia |
| 08/10/2011 | CN101164554B Application of valeriana jatamansi jones in preparing veterinary medicine for treating pica |
| 08/10/2011 | CN101085802B Method for preparing Notoginsen triterpenes |
| 08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994219 Approach to anti-microbial host defense with molecular shields with lipoxin compounds |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994159 inhibits proliferation of c-Kit kinase activated-cancer; also mastocytosis, allergy and asthma, which are considered to be caused by c-Kit kinase; 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide |
| 08/09/2011 | US7994152 Method of treating a cancer by administering A 2′,5′-oligoadenylate analog |
| 08/09/2011 | US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 08/09/2011 | US7993849 Human TIMP-1 antibodies |
| 08/09/2011 | US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy |
| 08/09/2011 | US7993829 HPRP4s modifiers of the p53 pathway and methods of use |
| 08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2512000C Selective estrogen receptor modulator |
| 08/09/2011 | CA2487727C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/09/2011 | CA2468811C Pharmaceutical use of cox-2 inhibitors in angiogenesis-mediated ocular disorders |
| 08/09/2011 | CA2459887C Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
| 08/09/2011 | CA2448927C Pharmaceutical composition |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2441534C Benzoaxathiepin derivatives and their use as medicines |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2438595C Glucopyranosyloxypyrazole derivatives and medicinal use thereof |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2428039C Serotonergic agents |
| 08/09/2011 | CA2380058C Novel peptides |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/09/2011 | CA2334941C Tnf-derived peptides for use in treating oedema |
| 08/09/2011 | CA2302809C Membrane virus host range mutations and their uses as vaccine substrates |
| 08/09/2011 | CA2293415C Compositions for treating and preventing arterial thrombosis and use of a factor xa inhibitor on its own and/or combined with a platelet antiaggregating agent |
| 08/04/2011 | WO2011093672A2 Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase |
| 08/04/2011 | WO2011093501A1 Gpr119 agonist |
| 08/04/2011 | WO2011093418A1 Agent for promoting differentiation of adipocyte precursor cells |
| 08/04/2011 | WO2011093290A1 Anti-inflammatory agent |
| 08/04/2011 | WO2011091719A1 Crystalline hydrates of alkyl acyl acetaldehyde sulfite, preparation methods and uses thereof |
| 08/04/2011 | WO2011091461A1 Compounds for use in the treatment of diseases |
| 08/04/2011 | US20110191873 Methods of Protein Destabilization and Uses Thereof |
| 08/04/2011 | US20110190611 Oxygenation procedures for newborns and devices for use therein |
| 08/04/2011 | US20110190566 Polymer microgel beads |